Stocks and Investing
Stocks and Investing
Mon, June 22, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sun, June 21, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, June 19, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (CDNA) at Strong Buy with Decreased Target to $37 on, Jun 19th, 2020
Raghuram Selvaraju of HC Wainwright & Co., Maintained "CareDx, Inc" (CDNA) at Strong Buy with Decreased Target from $40 to $37 on, Jun 19th, 2020.
Raghuram has made no other calls on CDNA in the last 4 months.
There is 1 other peer that has a rating on CDNA. Out of the 1 peers that are also analyzing CDNA, 0 agree with Raghuram's Rating of Hold.
This is the rating of the analyst that currently disagrees with Raghuram
- Yi Chen of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $40 on, Friday, May 1st, 2020